SCHEMBL4617427

SCHEMBL4617427

COC(=O)C1CC(Oc2cc(-c3ccccc3)nc3cc(OC)ccc23)CN1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
ALDH1A1 P00352 2/20 0.55
TACR3 P29371 8/20 0.49
PLA2G2A P14555 2/20 0.48
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
TDP1 Q9NUW8 2/20 0.44
MAPT P10636 2/20 0.43
HTT P42858 2/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
NPC1 O15118 1/20 0.43
MITF O75030 1/20 0.43
RAB9A P51151 1/20 0.43
PAX8 Q06710 1/20 0.43
PIM1 P11309 1/20 0.43
CTSB P07858 1/20 0.43
KLK7 P49862 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8354904 1.00 KDM4E (0.55) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL4981224 0.93 KDM4E (0.57) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL5692604 0.93 KDM4E (0.57) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL3052280 0.93 KDM4E (0.57) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL8203094 0.91 KDM4E (0.55) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
Hydrochloric Acid SCHEMBL4410289 0.89 HPGD (0.48) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL7095755 0.89 KDM4E (0.51) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL13451464 0.86 KDM4E (0.48) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL7096162 0.86 KDM4E (0.44) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL14095448 0.85 KMT2A (0.44) KDM4ESMN1; SMN2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881002-A1 HCV NS-3 serine protease inhibitors Tibotec Pharmaceuticals Ltd. (IE) 2008-01-23 EP disclosed